"Appetite Depressants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that are used to suppress appetite.
| Descriptor ID |
D001067
|
| MeSH Number(s) |
D27.505.954.427.140.155
|
| Concept/Terms |
Appetite Depressants- Appetite Depressants
- Depressants, Appetite
- Anorectics
- Anorexic Drugs
- Drugs, Anorexic
- Appetite Suppressants
- Suppressants, Appetite
- Appetite-Depressing Drugs
- Appetite Depressing Drugs
- Drugs, Appetite-Depressing
- Appetite-Suppressant Drugs
- Appetite Suppressant Drugs
- Drugs, Appetite-Suppressant
- Anorectic Agents
- Agents, Anorectic
- Anorexigenic Drugs
- Drugs, Anorexigenic
|
Below are MeSH descriptors whose meaning is more general than "Appetite Depressants".
Below are MeSH descriptors whose meaning is more specific than "Appetite Depressants".
This graph shows the total number of publications written about "Appetite Depressants" by people in this website by year, and whether "Appetite Depressants" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 1 | 2 |
| 2010 | 0 | 1 | 1 |
| 2013 | 1 | 1 | 2 |
| 2014 | 1 | 0 | 1 |
| 2017 | 1 | 1 | 2 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Appetite Depressants" by people in Profiles.
-
Gai/o-coupled Htr2c in the paraventricular nucleus of the hypothalamus antagonizes the anorectic effect of serotonin agents. Cell Rep. 2021 11 16; 37(7):109997.
-
Asprosin is a centrally acting orexigenic hormone. Nat Med. 2017 Dec; 23(12):1444-1453.
-
Effects of MetAP2 inhibition on hyperphagia and body weight in Prader-Willi syndrome: A randomized, double-blind, placebo-controlled trial. Diabetes Obes Metab. 2017 12; 19(12):1751-1761.
-
Neuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect. J Clin Invest. 2014 Jun; 124(6):2456-63.
-
Serotonin 2C receptors in pro-opiomelanocortin neurons regulate energy and glucose homeostasis. J Clin Invest. 2013 Dec; 123(12):5061-70.
-
The role of sibutramine in weight reduction. Bratisl Lek Listy. 2013; 114(3):155-7.
-
PI3K signaling in the ventromedial hypothalamic nucleus is required for normal energy homeostasis. Cell Metab. 2010 Jul 07; 12(1):88-95.
-
5-HT2CRs expressed by pro-opiomelanocortin neurons regulate energy homeostasis. Neuron. 2008 Nov 26; 60(4):582-9.
-
Effectiveness of Medifast supplements combined with obesity pharmacotherapy: a clinical program evaluation. Eat Weight Disord. 2008 Jun; 13(2):95-101.
-
Increasing prevalence of obesity and clustered cardiometabolic risk: can treatment of the underlying cause reverse the trends? Crit Pathw Cardiol. 2007 Jun; 6(2):41-5.